Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator

CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer

CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer

CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer

CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer